Literature DB >> 8070413

Smooth muscle-specific switching of alpha-tropomyosin mutually exclusive exon selection by specific inhibition of the strong default exon.

C Gooding1, G C Roberts, G Moreau, B Nadal-Ginard, C W Smith.   

Abstract

Exons 2 and 3 of alpha-tropomyosin are spliced in a strict mutually exclusive manner. Exon 3 is a default choice, being selected in almost all cell types where the gene is expressed. The default selection arises from a competition between the two exons, in which the stronger branch point/pyrimidine tract elements of exon 3 win. Exon 2 is selected predominantly or exclusively only in smooth muscle cells. We show here that the basis for the smooth muscle-specific switching of exon selection is inhibition of exon 3. Exon 3 is still skipped with smooth muscle specificity, even in the absence of exon 2. We have defined two conserved sequence elements, one in each of the introns flanking exon 3, that are essential for this regulation. Mutation of either element severely impairs regulated suppression of exon 3. No other exon or intron sequences appear to be necessary for regulation. We have also demonstrated skipping of exon 3 that is dependent upon both regulatory elements in an in vitro splicing assay. We further show that both splice sites of exon 3 must be inhibited in a concerted fashion to switch to selection of exon 2. This may relate to the requirement for negative elements on both sides of the exon.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8070413      PMCID: PMC395299          DOI: 10.1002/j.1460-2075.1994.tb06697.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  Cloning and domain structure of the mammalian splicing factor U2AF.

Authors:  P D Zamore; J G Patton; M R Green
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

2.  Alpha-tropomyosin mutually exclusive exon selection: competition between branchpoint/polypyrimidine tracts determines default exon choice.

Authors:  M P Mullen; C W Smith; J G Patton; B Nadal-Ginard
Journal:  Genes Dev       Date:  1991-04       Impact factor: 11.361

3.  RNA secondary structure repression of a muscle-specific exon in HeLa cell nuclear extracts.

Authors:  B Clouet d'Orval; Y d'Aubenton Carafa; P Sirand-Pugnet; M Gallego; E Brody; J Marie
Journal:  Science       Date:  1991-06-28       Impact factor: 47.728

4.  Tissue-specific splicing in vivo of the beta-tropomyosin gene: dependence on an RNA secondary structure.

Authors:  D Libri; A Piseri; M Y Fiszman
Journal:  Science       Date:  1991-06-28       Impact factor: 47.728

5.  Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing.

Authors:  J G Patton; S A Mayer; P Tempst; B Nadal-Ginard
Journal:  Genes Dev       Date:  1991-07       Impact factor: 11.361

Review 6.  Alternative splicing in the control of gene expression.

Authors:  C W Smith; J G Patton; B Nadal-Ginard
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

7.  General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer.

Authors:  Q Sun; A Mayeda; R K Hampson; A R Krainer; F M Rottman
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

8.  Alternative splicing of beta-tropomyosin pre-mRNA: cis-acting elements and cellular factors that block the use of a skeletal muscle exon in nonmuscle cells.

Authors:  W Guo; G J Mulligan; S Wormsley; D M Helfman
Journal:  Genes Dev       Date:  1991-11       Impact factor: 11.361

9.  Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.

Authors:  A Mayeda; A R Krainer
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

10.  The chicken gene encoding the alpha isoform of tropomyosin of fast-twitch muscle fibers: organization, expression and identification of the major proteins synthesized.

Authors:  M Lemonnier; L Balvay; V Mouly; D Libri; M Y Fiszman
Journal:  Gene       Date:  1991-11-15       Impact factor: 3.688

View more
  49 in total

1.  Multiple splicing defects in an intronic false exon.

Authors:  H Sun; L A Chasin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  SRp30c is a repressor of 3' splice site utilization.

Authors:  Martin J Simard; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

3.  Combinatorial control of a neuron-specific exon.

Authors:  E F Modafferi; D L Black
Journal:  RNA       Date:  1999-05       Impact factor: 4.942

Review 4.  Polypyrimidine tract binding protein antagonizes exon definition.

Authors:  E J Wagner; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

5.  Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon.

Authors:  F Del Gatto; A Plet; M C Gesnel; C Fort; R Breathnach
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 6.  Diverse regulation of 3' splice site usage.

Authors:  Muhammad Sohail; Jiuyong Xie
Journal:  Cell Mol Life Sci       Date:  2015-09-14       Impact factor: 9.261

7.  An apparent pseudo-exon acts both as an alternative exon that leads to nonsense-mediated decay and as a zero-length exon.

Authors:  Sushma-Nagaraja Grellscheid; Christopher W J Smith
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

8.  Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein.

Authors:  Natalia Gromak; Arianne J Matlin; Thomas A Cooper; Christopher W J Smith
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

9.  The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms.

Authors:  A Moreira; Y Takagaki; S Brackenridge; M Wollerton; J L Manley; N J Proudfoot
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

10.  A splicing silencer that regulates smooth muscle specific alternative splicing is active in multiple cell types.

Authors:  Natalia Gromak; Christopher W J Smith
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.